SGS is supported by a Cancer Research UK Postdoctoral Fellowship (C42785/A17965). AF is supported by a Cancer Research UK—BUPA Cancer Prevention Postdoctoral Fellowship (C49896/A17429). RH is supported by NIHR Collaboration for Leadership in Applied Research and Care (CLAHRC) North Thame
BACKGROUND: Breast Cancer incidence in the UK is estimated to rise to 71,000 per year by 2035. Preve...
Context: Breast cancer chemoprevention is recognized as an effective strategy for risk reduction in ...
Q4Q2Objective: To assess the determinants of the participation rate in breast cancer screening progr...
Background: The effectiveness of preventive therapy for breast cancer depends on adequate uptake, bu...
Smith is supported by a Cancer Research UK Postdoctoral Fellowship (C42785/A17965). RH supported by ...
Chemoprevention for women at risk for breast cancer has been shown to be effective, but in actual pr...
This is a post-peer-review, pre-copyedit version of an article published in Breast Cancer Research a...
Purpose: Uptake of preventive therapy for women at increased breast cancer risk in England is unknow...
A health-conscious lifestyle may protect against breast cancer in situ. However, breast cancer in si...
Purpose: Uptake of preventive therapy for women at increased breast cancer risk in England is unknow...
Breast cancer is a commonly diagnosed neoplastic ailment in females particularly near menopause. Thi...
In England, the National Institute for Health and Care Excellence guideline for familial breast canc...
Introduction: Uptake of preventive therapies for breast cancer is low. We examined whether women at ...
Zoe Moon, Rona Moss-Morris, Myra S Hunter, Sophie Carlisle, Lyndsay D Hughes Health Psychology Sect...
Chemoprevention for women at risk for breast cancer has been shown to be effective, but in actual pr...
BACKGROUND: Breast Cancer incidence in the UK is estimated to rise to 71,000 per year by 2035. Preve...
Context: Breast cancer chemoprevention is recognized as an effective strategy for risk reduction in ...
Q4Q2Objective: To assess the determinants of the participation rate in breast cancer screening progr...
Background: The effectiveness of preventive therapy for breast cancer depends on adequate uptake, bu...
Smith is supported by a Cancer Research UK Postdoctoral Fellowship (C42785/A17965). RH supported by ...
Chemoprevention for women at risk for breast cancer has been shown to be effective, but in actual pr...
This is a post-peer-review, pre-copyedit version of an article published in Breast Cancer Research a...
Purpose: Uptake of preventive therapy for women at increased breast cancer risk in England is unknow...
A health-conscious lifestyle may protect against breast cancer in situ. However, breast cancer in si...
Purpose: Uptake of preventive therapy for women at increased breast cancer risk in England is unknow...
Breast cancer is a commonly diagnosed neoplastic ailment in females particularly near menopause. Thi...
In England, the National Institute for Health and Care Excellence guideline for familial breast canc...
Introduction: Uptake of preventive therapies for breast cancer is low. We examined whether women at ...
Zoe Moon, Rona Moss-Morris, Myra S Hunter, Sophie Carlisle, Lyndsay D Hughes Health Psychology Sect...
Chemoprevention for women at risk for breast cancer has been shown to be effective, but in actual pr...
BACKGROUND: Breast Cancer incidence in the UK is estimated to rise to 71,000 per year by 2035. Preve...
Context: Breast cancer chemoprevention is recognized as an effective strategy for risk reduction in ...
Q4Q2Objective: To assess the determinants of the participation rate in breast cancer screening progr...